To view this email as a web page, click here.
 
SPECIALTY DRUGS
 
Oral specialty drug options on the horizon
Find out the top oral specialty drugs that are on the horizon.
Read more
 
FDA warns Pfizer’s Meridian over EpiPen
FDA warned about an injunction or seizure if Meridian Medical Technologies, a division of Pfizer, does not correct its problems with the EpiPen.
Find out why
 
FDA warns about deaths in cancer drug trials
An increased risk of deaths for patients in clinical trials receiving this blockbuster cancer drug, as well as 2 other drugs, led FDA to stop the trials.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.